Raymond James Upgrades Hospira (HSP) to Market Perform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Hospira (HSP) Tops Q3 EPS by 21c; Sees FY EPS at Upper End of Prior Range
November 6, 2014 7:38 AM ESTHospira (NYSE: HSP) reported Q3 EPS of $0.74, $0.21 better than the analyst estimate of $0.53. Revenue for the quarter came in at $1.15 billion versus the consensus estimate of $1.08 billion.
Hospira sees FY2014 EPS of $2.40-$2.50, the upper-end of its prior range.
For earnings history and earnings-related data on Hospira (HSP) click here.
... More